Literature DB >> 19843543

Proteotoxic stress increases nuclear localization of ataxin-3.

Christopher P Reina1, Xiaoyan Zhong, Randall N Pittman.   

Abstract

Spinocerebellar ataxia type 3 (SCA3)/Machado Joseph disease results from expansion of the polyglutamine domain in ataxin-3 (Atx3). Atx3 is a transcriptional co-repressor, as well as a deubiquitinating enzyme that appears to function in cellular pathways involved in protein homeostasis. In this study, we show that interactions of Atx3 with valosin-containing protein and hHR23B are dynamic and modulated by proteotoxic stresses. Heat shock, a general proteotoxic stress, also induced wild-type and pathogenic Atx3 to accumulate in the nucleus. Mapping studies showed that two regions of Atx3, the Josephin domain and the C-terminus, regulated heat shock-induced nuclear localization. Heat shock-induced nuclear localization of Atx3 was not affected by a casein kinase-2 inhibitor or by mutating a predicted nuclear localization signal. However, serine-111 of Atx3 was required for nuclear localization of the Josephin domain and regulated nuclear localization of full-length Atx3. Atx3 null cells were more sensitive to toxic effects of heat shock suggesting that Atx3 had a protective function in the cellular response to heat shock. Importantly, we found that oxidative stress also induced nuclear localization of Atx3; both wild-type and pathogenic Atx3 accumulated in the nucleus of SCA3 patient fibroblasts following oxidative stress. Heat shock and oxidative stress are the first processes identified that increase nuclear localization of Atx3. Observations in this study provide new and important insights for understanding SCA3 pathology as the nucleus is likely a key site for early pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19843543      PMCID: PMC2796889          DOI: 10.1093/hmg/ddp482

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  65 in total

1.  A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking.

Authors:  J M Stommel; N D Marchenko; G S Jimenez; U M Moll; T J Hope; G M Wahl
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

2.  Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells.

Authors:  A Kazantsev; E Preisinger; A Dranovsky; D Goldgaber; D Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

3.  Nuclear targeting of mutant Huntingtin increases toxicity.

Authors:  M F Peters; F C Nucifora; J Kushi; H C Seaman; J K Cooper; W J Herring; V L Dawson; T M Dawson; C A Ross
Journal:  Mol Cell Neurosci       Date:  1999-08       Impact factor: 4.314

4.  Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.

Authors:  Y Chai; S L Koppenhafer; S J Shoesmith; M K Perez; H L Paulson
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

5.  Heterogeneous intracellular localization and expression of ataxin-3.

Authors:  Y Trottier; G Cancel; I An-Gourfinkel; Y Lutz; C Weber; A Brice; E Hirsch; J L Mandel
Journal:  Neurobiol Dis       Date:  1998-11       Impact factor: 5.996

6.  Oxidative stress in neurodegeneration in dentatorubral-pallidoluysian atrophy.

Authors:  Rie Miyata; Masaharu Hayashi; Naoyuki Tanuma; Kei Shioda; Ryou Fukatsu; Shuki Mizutani
Journal:  J Neurol Sci       Date:  2007-10-18       Impact factor: 3.181

7.  Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation.

Authors:  An-Hsun Chou; Tu-Hsueh Yeh; Pin Ouyang; Ying-Ling Chen; Si-Ying Chen; Hung-Li Wang
Journal:  Neurobiol Dis       Date:  2008-05-27       Impact factor: 5.996

Review 8.  Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging.

Authors:  Richard I Morimoto
Journal:  Genes Dev       Date:  2008-06-01       Impact factor: 11.361

Review 9.  Adapting proteostasis for disease intervention.

Authors:  William E Balch; Richard I Morimoto; Andrew Dillin; Jeffery W Kelly
Journal:  Science       Date:  2008-02-15       Impact factor: 63.714

10.  Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation.

Authors:  M K Perez; H L Paulson; S J Pendse; S J Saionz; N M Bonini; R N Pittman
Journal:  J Cell Biol       Date:  1998-12-14       Impact factor: 10.539

View more
  34 in total

Review 1.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

2.  The de-ubiquitinating enzyme ataxin-3 does not modulate disease progression in a knock-in mouse model of Huntington disease.

Authors:  Li Zeng; Sara J Tallaksen-Greene; Bo Wang; Roger L Albin; Henry L Paulson
Journal:  J Huntingtons Dis       Date:  2013

3.  Divalproex sodium modulates nuclear localization of ataxin-3 and prevents cellular toxicity caused by expanded ataxin-3.

Authors:  Zi-Jian Wang; Aoife Hanet; Daniel Weishäupl; Inês M Martins; Anna S Sowa; Olaf Riess; Thorsten Schmidt
Journal:  CNS Neurosci Ther       Date:  2018-01-09       Impact factor: 5.243

4.  Interaction of the polyglutamine protein ataxin-3 with Rad23 regulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3.

Authors:  Joanna R Sutton; Jessica R Blount; Kozeta Libohova; Wei-Ling Tsou; Gnanada S Joshi; Henry L Paulson; Maria do Carmo Costa; K Matthew Scaglione; Sokol V Todi
Journal:  Hum Mol Genet       Date:  2017-04-15       Impact factor: 6.150

5.  Nuclear aggregation of polyglutamine-expanded ataxin-3: fragments escape the cytoplasmic quality control.

Authors:  Peter Breuer; Annette Haacke; Bernd O Evert; Ullrich Wüllner
Journal:  J Biol Chem       Date:  2010-01-11       Impact factor: 5.157

Review 6.  Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.

Authors:  Qian Huang; Maria E Figueiredo-Pereira
Journal:  Apoptosis       Date:  2010-11       Impact factor: 4.677

7.  The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its neuroprotective role in Drosophila melanogaster.

Authors:  Wei-Ling Tsou; Michelle Ouyang; Ryan R Hosking; Joanna R Sutton; Jessica R Blount; Aaron A Burr; Sokol V Todi
Journal:  Neurobiol Dis       Date:  2015-05-22       Impact factor: 5.996

Review 8.  Bioanalysis of eukaryotic organelles.

Authors:  Chad P Satori; Michelle M Henderson; Elyse A Krautkramer; Vratislav Kostal; Mark D Distefano; Mark M Distefano; Edgar A Arriaga
Journal:  Chem Rev       Date:  2013-04-10       Impact factor: 60.622

9.  Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23.

Authors:  Jessica R Blount; Wei-Ling Tsou; Gorica Ristic; Aaron A Burr; Michelle Ouyang; Holland Galante; K Matthew Scaglione; Sokol V Todi
Journal:  Nat Commun       Date:  2014-08-21       Impact factor: 14.919

10.  Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line.

Authors:  Lauren R Moore; Laura Keller; David D Bushart; Rodrigo G Delatorre; Duojia Li; Hayley S McLoughlin; Maria do Carmo Costa; Vikram G Shakkottai; Gary D Smith; Henry L Paulson
Journal:  Stem Cell Res       Date:  2019-07-16       Impact factor: 2.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.